BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37130203)

  • 1. A Novel Method to Detect Copy Number Variation in Melanoma: Droplet Digital PCR for Quantitation of the CDKN2A Gene, a Proof-of-Concept Study.
    McFadden JR; Syku M; Barney RE; Stevanovic M; Chaudhari AS; O'Hern KJ; Chambers M; Baker CM; LeBlanc RE; Doan L; Tsongalis GJ; Hughes EG; Sriharan A
    Am J Dermatopathol; 2023 Jul; 45(7):454-462. PubMed ID: 37130203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel method to assess copy number variation in melanoma: Droplet digital PCR for precise quantitation of the RREB1 gene in formalin-fixed, paraffin-embedded melanocytic neoplasms, a proof-of-concept study.
    O'Hern K; Barney R; Chambers M; Baker C; Stevanovic M; Tsongalis GJ; Hughes E; Sriharan A
    J Cutan Pathol; 2023 Feb; 50(2):169-177. PubMed ID: 36325821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel method to assess copy number variations in melanocytic neoplasms: Droplet digital PCR for precise quantitation of MYC and MYB genes.
    Ramos-Rodriguez AJ; McFadden JR; Momtahen S; LeBlanc RE; Yan S; Chaudhari AS; Cloutier JM; Stevanovic M; Barney R; Syku M; Lozano-Franco M; Hughes E; Sriharan A
    J Cutan Pathol; 2024 Feb; 51(2):146-154. PubMed ID: 37795541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
    Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
    Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
    Gammon B; Beilfuss B; Guitart J; Gerami P
    Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitotically Active Nevus and Nevoid Melanoma: A Clinicopathological and Molecular Study.
    Mesbah Ardakani N; Singh S; Thomas C; Van Vliet C; Harvey NT; Calonje JE; Wood BA
    Am J Dermatopathol; 2021 Mar; 43(3):182-190. PubMed ID: 32649342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Spitz Tumors: A Diagnostic Challenge.
    Harms KL; Lowe L; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p16-Ki-67-HMB45 Immunohistochemistry Scoring System is Highly Concordant With the Fluorescent In Situ Hybridization Test to Differentiate Between Melanocytic Nevi and Melanomas.
    Uguen A; Uguen M; Guibourg B; Talagas M; Marcorelles P; De Braekeleer M
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):361-367. PubMed ID: 27490764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Amount of Melanin Influences p16 Loss in Spitzoid Melanocytic Lesions: Correlation With CDKN2A Status by FISH and MLPA.
    Martinez Ciarpaglini C; Gonzalez J; Sanchez B; Agusti J; Navarro L; Nieto G; Monteagudo C
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):423-429. PubMed ID: 29489509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating melanocytic lesions with single nucleotide polymorphism (SNP) chromosomal microarray.
    Hedayat AA; Linos K; Jung HS; Tafe LJ; Yan S; LeBlanc RE; Lefferts JA
    Exp Mol Pathol; 2017 Dec; 103(3):279-287. PubMed ID: 29169801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA): Its usefulness as an adjunctive diagnostic tool for melanocytic tumors.
    Takata M; Suzuki T; Ansai S; Kimura T; Shirasaki F; Hatta N; Saida T
    J Dermatol Sci; 2005 Oct; 40(1):51-7. PubMed ID: 16054806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9p21 gene locus in Spitz nevi of older individuals: absence of cytogenetic and immunohistochemical findings associated with malignancy.
    Horst BA; Terrano D; Fang Y; Silvers DN; Busam KJ
    Hum Pathol; 2013 Dec; 44(12):2822-8. PubMed ID: 24134932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p16 Range of expression in dermal predominant benign epithelioid and spindled nevi and melanoma.
    Oaxaca G; Billings SD; Ko JS
    J Cutan Pathol; 2020 Sep; 47(9):815-823. PubMed ID: 32330325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH.
    Carter MD; Durham AB; Miedema JR; Harms PW; Chan MP; Patel RM; Lowe L; Fullen DR; Hristov AC; Wang M; Andea AA
    Hum Pathol; 2019 Apr; 86():115-123. PubMed ID: 30576704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.
    Bastian BC
    Oncogene; 2003 May; 22(20):3081-6. PubMed ID: 12789284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma.
    Gerami P; Jewell SS; Morrison LE; Blondin B; Schulz J; Ruffalo T; Matushek P; Legator M; Jacobson K; Dalton SR; Charzan S; Kolaitis NA; Guitart J; Lertsbarapa T; Boone S; LeBoit PE; Bastian BC
    Am J Surg Pathol; 2009 Aug; 33(8):1146-56. PubMed ID: 19561450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.